Feb-04-21 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
Sep-02-20 Initiated
Robert W. Baird
Outperform
$175
Jun-09-20 Initiated
Needham
Hold
Jul-10-19 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jan-03-18 Downgrade
Raymond James
Outperform → Mkt Perform
Jun-05-17 Downgrade
Wellington Shields
Gradually Accumulate → Hold
May-03-17 Upgrade
KeyBanc Capital Mkts
Sector Weight → Overweight
Nov-30-16 Initiated
Goldman
Neutral
$71
Jun-03-16 Upgrade
Northcoast
Neutral → Buy
Jun-12-15 Downgrade
Raymond James
Strong Buy → Outperform
May-07-13 Downgrade
Griffin Securities
Buy → Hold
Feb-08-13 Reiterated
Griffin Securities
Buy
$40 → $45
Aug-03-12 Upgrade
JMP Securities
Mkt Perform → Mkt Outperform
Feb-08-12 Downgrade
JMP Securities
Mkt Outperform → Mkt Perform
Nov-03-11 Reiterated
JMP Securities
Mkt Outperform
$39 → $37
Feb-09-11 Reiterated
JMP Securities
Mkt Outperform
$43 → $39
Dec-21-10 Reiterated
JMP Securities
Mkt Outperform
$36 → $43
Sep-17-10 Initiated
JMP Securities
Mkt Outperform
$36
Apr-07-10 Reiterated
CL King
Strong Buy
$46 → $49
Mar-26-10 Initiated
CL King
Strong Buy
$46
Feb-22-21 10:13AM
Feb-18-21 01:28AM
Feb-12-21 02:14PM
Feb-09-21 03:37PM
Feb-03-21 10:30AM
08:15AM
07:00AM
Feb-02-21 05:55PM
04:48PM
04:30PM
Feb-01-21 10:55AM
10:06AM
Jan-29-21 10:29AM
Jan-26-21 12:31PM
Jan-19-21 04:30PM
Jan-18-21 08:22AM
Jan-13-21 07:30PM
09:15AM
Jan-12-21 05:06PM
01:29PM
12:22PM
09:51AM
07:26AM
07:12AM
Jan-07-21 05:14PM
Dec-21-20 02:13PM
Dec-18-20 03:51AM
Dec-02-20 11:31AM
Nov-19-20 09:27AM
Nov-18-20 04:30PM
07:45AM
12:12AM
Nov-04-20 11:40AM
Nov-03-20 12:47PM
09:17AM
08:15AM
Nov-02-20 05:55PM
04:30PM
Oct-30-20 12:51PM
Oct-28-20 11:51AM
07:55AM
Oct-26-20 12:31PM
Oct-22-20 12:38PM
Oct-20-20 07:00AM
Oct-08-20 09:15AM
Oct-06-20 07:00AM
Sep-22-20 12:31PM
Sep-21-20 09:50AM
Sep-08-20 03:14PM
Sep-02-20 11:30AM
Aug-21-20 07:27AM
Aug-08-20 09:31AM
Aug-04-20 10:28AM
Aug-03-20 05:45PM
04:30PM
Jul-31-20 11:15AM
Jul-28-20 11:52AM
Jul-27-20 12:31PM
Jul-22-20 04:30PM
Jul-09-20 09:22PM
Jun-16-20 10:24AM
Jun-15-20 11:08AM
Jun-03-20 03:30AM
May-26-20 07:00AM
May-21-20 03:48PM
May-15-20 10:18AM
May-13-20 05:55PM
04:30PM
May-12-20 10:04AM
May-06-20 12:30PM
May-04-20 12:59PM
Apr-30-20 07:00AM
Apr-27-20 12:31PM
Apr-13-20 03:31PM
09:52AM
Apr-10-20 02:08PM
12:07PM
Apr-09-20 10:39AM
Apr-06-20 09:17AM
Apr-02-20 10:04AM
Mar-31-20 08:56AM
Mar-23-20 09:04AM
Mar-20-20 08:54AM
Mar-18-20 09:06PM
06:07PM Investor's Business Daily
Mar-11-20 11:30AM
Mar-10-20 12:33PM
Mar-04-20 09:02AM
Mar-02-20 08:48AM
Feb-26-20 05:17PM
10:09AM
08:10AM
Feb-25-20 09:28AM
Feb-24-20 09:01AM
Feb-21-20 09:54AM
08:34AM
08:32AM
Feb-20-20 09:46AM
Feb-19-20 09:11AM
08:31AM
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Madsen Julia Senior VP, Life Sciences Jan 08 Option Exercise 67.22 1,000 67,221 5,641 Jan 08 04:33 PM Madsen Julia Senior VP, Life Sciences Jan 08 Sale 202.00 1,000 202,000 4,641 Jan 08 04:33 PM LEWIS DAVID B Director Dec 01 Option Exercise 31.61 1,560 49,312 8,244 Dec 02 04:34 PM LEWIS DAVID B Director Dec 01 Sale 193.79 1,560 302,312 6,684 Dec 02 04:34 PM Madsen Julia Senior VP, Life Sciences Nov 09 Option Exercise 48.78 1,900 92,690 6,541 Nov 10 04:33 PM Rosebrough Walter M Jr President & CEO Nov 09 Sale 193.89 10,000 1,938,945 51,405 Nov 10 04:35 PM Madsen Julia Senior VP, Life Sciences Nov 09 Sale 192.44 1,900 365,636 4,641 Nov 10 04:33 PM Rosebrough Walter M Jr President & CEO Nov 06 Sale 181.39 10,000 1,813,921 61,405 Nov 09 04:35 PM Burton Karen L VP, Controller & CAO Nov 05 Option Exercise 0.00 2,852 0 10,746 Nov 09 04:32 PM Majors Cary L Sr VP N America Com Operations Nov 05 Sale 180.00 2,000 360,000 15,120 Nov 09 04:34 PM Burton Karen L VP, Controller & CAO Nov 05 Sale 179.42 4,602 825,682 6,144 Nov 09 04:32 PM TOKICH MICHAEL J Sr. Vice Pres., CFO Oct 09 Option Exercise 53.52 27,920 1,494,278 73,442 Oct 13 04:34 PM TOKICH MICHAEL J Sr. Vice Pres., CFO Oct 09 Sale 188.18 27,920 5,253,985 45,522 Oct 13 04:34 PM TOKICH MICHAEL J Sr. Vice Pres., CFO Oct 08 Option Exercise 53.52 80 4,282 45,602 Oct 13 04:34 PM TOKICH MICHAEL J Sr. Vice Pres., CFO Oct 08 Sale 187.00 80 14,960 45,522 Oct 13 04:34 PM Carestio Daniel A Sr VP and Chief Operating Off Oct 06 Option Exercise 77.07 13,500 1,040,445 39,814 Oct 08 04:32 PM Carestio Daniel A Sr VP and Chief Operating Off Oct 06 Sale 182.17 13,500 2,459,277 26,314 Oct 08 04:32 PM Zangerle John Adam Sr. VP, Gen Counsel, and Sec. Oct 01 Option Exercise 53.52 12,252 655,727 41,136 Oct 02 04:35 PM Zangerle John Adam Sr. VP, Gen Counsel, and Sec. Oct 01 Sale 178.00 12,252 2,180,856 28,884 Oct 02 04:35 PM Carestio Daniel A Sr VP and Chief Operating Off Sep 18 Option Exercise 69.72 15,000 1,045,800 41,314 Sep 21 04:38 PM Carestio Daniel A Sr VP and Chief Operating Off Sep 18 Sale 175.52 15,000 2,632,757 26,314 Sep 21 04:38 PM Carestio Daniel A Sr VP and Chief Operating Off Sep 15 Option Exercise 67.98 8,000 543,840 34,314 Sep 17 04:33 PM Carestio Daniel A Sr VP and Chief Operating Off Sep 15 Sale 169.58 8,000 1,356,669 26,314 Sep 17 04:33 PM Zangerle John Adam Sr. VP, Gen Counsel, and Sec. Sep 14 Sale 167.00 2,000 334,000 28,884 Sep 15 04:34 PM Breeden Richard C Director Aug 25 Sale 154.37 20,000 3,087,493 27,242 Aug 26 04:33 PM Breeden Richard C Director Aug 24 Sale 152.67 25,000 3,816,809 47,242 Aug 26 04:33 PM Majors Cary L Sr VP N America Com Operations Aug 10 Option Exercise 69.72 3,000 209,160 22,475 Aug 12 04:30 PM Majors Cary L Sr VP N America Com Operations Aug 10 Sale 155.88 218 33,982 0 Aug 12 04:30 PM Majors Cary L Sr VP N America Com Operations Aug 10 Sale 156.31 5,355 837,016 17,120 Aug 12 04:30 PM Rosebrough Walter M Jr President & CEO Aug 07 Option Exercise 77.07 51,000 3,930,570 127,302 Aug 10 04:31 PM Rosebrough Walter M Jr President & CEO Aug 07 Sale 153.96 51,000 7,852,021 76,302 Aug 10 04:31 PM Rosebrough Walter M Jr President & CEO Aug 06 Option Exercise 74.46 79,085 5,888,656 127,302 Aug 10 04:31 PM Rosebrough Walter M Jr President & CEO Aug 06 Sale 155.67 71,085 11,065,857 76,302 Aug 10 04:31 PM Sohi Mohsen Director May 29 Option Exercise 32.36 3,218 104,134 25,579 Jun 01 04:35 PM Sohi Mohsen Director May 29 Sale 164.12 3,218 528,126 22,361 Jun 01 04:35 PM Breeden Richard C Director Mar 05 Option Exercise 32.34 3,133 101,321 31,681 Mar 06 04:31 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite